Douglas T. Sheehy - Net Worth and Insider Trading
Douglas T. Sheehy Net Worth
The estimated net worth of Douglas T. Sheehy is at least $2 Million dollars as of 2024-05-25. Douglas T. Sheehy is the See Remarks of Aimmune Therapeutics Inc and owns about 45,668 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $2 Million. Douglas T. Sheehy is also the SVP, General Counsel & Sec. of Codexis Inc and owns about 69,200 shares of Codexis Inc (CDXS) stock worth over $219,364. Details can be seen in Douglas T. Sheehy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas T. Sheehy has not made any transactions after 2020-01-16 and currently still holds the listed stock(s).
Transaction Summary of Douglas T. Sheehy
Douglas T. Sheehy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas T. Sheehy owns 2 companies in total, including Aimmune Therapeutics Inc (AIMT) , and Codexis Inc (CDXS) .
Click here to see the complete history of Douglas T. Sheehy’s form 4 insider trades.
Insider Ownership Summary of Douglas T. Sheehy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-10-10 | See Remarks |
| CDXS | Codexis Inc | 2013-11-13 | SVP & General Counsel & Sec. |
Douglas T. Sheehy Latest Holdings Summary
Douglas T. Sheehy currently owns a total of 2 stocks. Among these stocks, Douglas T. Sheehy owns 45,668 shares of Aimmune Therapeutics Inc (AIMT) as of January 16, 2020, with a value of $2 Million and a weighting of 87.78%. Douglas T. Sheehy also owns 69,200 shares of Codexis Inc (CDXS) as of September 14, 2012, with a value of $219,364 and a weighting of 12.22%.
Latest Holdings of Douglas T. Sheehy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-01-16 | 45,668 | 34.49 | 1,575,089 |
| CDXS | Codexis Inc | 2012-09-14 | 69,200 | 3.17 | 219,364 |
Holding Weightings of Douglas T. Sheehy
Douglas T. Sheehy Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas T. Sheehy has made a total of 2 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Aimmune Therapeutics Inc is the sale of 400 shares on January 16, 2020, which brought Douglas T. Sheehy around $14,800.
According to the SEC Form 4 filings, Douglas T. Sheehy has made a total of 0 transactions in Codexis Inc (CDXS) over the past 5 years. The most-recent trade in Codexis Inc is the sale of 3,800 shares on September 14, 2012, which brought Douglas T. Sheehy around $10,488.
Insider Trading History of Douglas T. Sheehy
- 1
Douglas T. Sheehy Trading Performance
GuruFocus tracks the stock performance after each of Douglas T. Sheehy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas T. Sheehy is 28.63%. GuruFocus also compares Douglas T. Sheehy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas T. Sheehy within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas T. Sheehy's insider trading performs compared to the benchmark.
Performance of Douglas T. Sheehy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.25 | | | | | |
| Relative Return to S&P 500(%) | 2.28 | | | | | |
Douglas T. Sheehy Ownership Network
Douglas T. Sheehy Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Douglas T. Sheehy is the See Remarks of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Douglas T. Sheehy Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas T. Sheehy. You might contact Douglas T. Sheehy via mailing address: C/o Aimmune Therapeutics, Inc., 8000 Marina Boulevard, Suite 300, Brisbane Ca 94005-1884.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
